Nanomaterial assisted natural killer cell therapy

Area of Science:

• Immunology and Cancer Therapy
• Nanomedicine

Background:

• Increasing cancer incidence drives interest in immune cell therapies.
• Natural Killer (NK) cells are crucial immune components with expanding applications in tumor treatment.
• Nanomaterials are increasingly integrated into NK cell-based cancer therapies.

Purpose of the Study:

• To comprehensively review NK cell biology, classification, distribution, receptor activation, and cytotoxicity.
• To explore diverse NK cell therapies, including CAR-NK technology, gene editing, and combination strategies.
• To examine the role of nanomaterials in modulating the tumor microenvironment and immune regulation for NK cell therapy.

Main Methods:

• Review of NK cell biology, including receptor mechanisms and cytotoxicity.
• Analysis of various NK cell therapy sources, expansion techniques, and CAR-NK development.
• Investigation into nanoparticle applications for immune regulation and tumor microenvironment modulation.

Main Results:

• NK cell therapy, particularly CAR-NK technology, demonstrates significant potential in cancer treatment.
• Nanomaterials offer promising strategies to enhance the efficacy of NK cell-based immunotherapies.
• Current CAR-NK technology faces certain limitations that require further investigation and optimization.

Conclusions:

• Optimizing NK cell therapy and addressing CAR-NK limitations are critical for clinical advancement.
• Further research into nanomaterial mechanisms and development is essential for improved therapeutic outcomes.
• Integrating nanomaterials with NK cell therapy holds substantial promise for future cancer treatment strategies.